John Radford^1,2*, Joanna Williams^2,3*, Darren Edwards^4*, Ruth Pettengell^5*, Peter Johnson^6*, Peter Hoskin^1,2*, Timothy Illidge^1,2* and Nicholas Counsell^4*

¹University of Manchester, Manchester, United Kingdom
²The Christie NHS Foundation Trust, Manchester, United Kingdom
³University of Manchester, Manchester, ENG, United Kingdom
⁴University College London, Cancer Trials Centre, London, United Kingdom
⁵St George's Hospital, London, United Kingdom
⁶School of Cancer Sciences, University of Southampton, Southampton, United Kingdom

Steven I. Park, MD¹, Stephen M. Ansell, MD, PhD², Danielle Boselli, MS^3*, Sharmila Giri^4*, Jakub Svoboda, MD⁵, Stephen D Smith, MD^6*, Tatyana Feldman, MD^7*, L. Elizabeth Budde, MD, PhD^8*, Andrew J Ness^4*, Philip Bierman, MD^9* and Hun Ju Lee, MD¹⁰

¹Department of Hematologic Oncology and Blood Disorders, Wake Forest Comprehensive Cancer Center, Levine Cancer Institue, Atrium Health, Charlotte, NC
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
⁴Department of Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Division of Medical Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA
⁷John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ
⁸Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁹Division of Oncology and Hematology, University of Nebraska, Omaha, NE
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Ann S. LaCasce, MD, MMSc¹, Deepa Jagadeesh, MD², Hun Ju Lee, MD³, Lu Chen^4*, David A. Bond, MD, BS⁵, Matthew Weinstock^6*, Matthew Mei, MD⁷, Tatyana Feldman, MD⁸, Allison M. Winter, MD², Jeffrey A. Barnes, MD, PhD⁹, Amitkumar N. Mehta, MD¹⁰, Gaurav Goyal, MD¹¹, Sairah Ahmed, MD³, Lisa Giulino Roth, MD¹², Azra Borogovac, MD¹³, Kristie A. Blum, MD¹⁴, Jane N Winter, MD¹⁵, Mehdi Hamadani, MD¹⁶, Sonali M. Smith, MD¹⁷, Philippe Armand, MD, PhD¹⁸, Ian W. Flinn, MD, PhD¹⁹, Jeremy S. Abramson, MD²⁰ and Alex F. Herrera, MD⁴

¹Dana-Farber Cancer Institute, Boston, MA
²Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴City of Hope, Duarte, CA
⁵Division of Hematology, The Ohio State University, Columbus, OH
⁶Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA
⁷City of Hope Cancer Center, Duarte, CA
⁸John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁹Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
¹⁰O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
¹¹Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL
¹²Weill Cornell Medicine, New York, NY
¹³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁴Winship Cancer Institute of Emory University, Atlanta, GA
¹⁵Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
¹⁶Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁷University of Chicago, Chicago, IL
¹⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁹Tennessee Oncology, Nashville, TN
²⁰Massachusetts General Hospital Cancer Center, Boston, MA

Jeremy S. Abramson, MD¹, David J. Straus, MD², Nancy L. Bartlett, MD³, John M. Burke⁴, Ryan C. Lynch, MD⁵, Eva Domingo Domenech, MD^6*, Brian Hess, MD⁷, Steven Schuster⁸, Yuliya Linhares, MD^9*, Rod Ramchandren, MD¹⁰, Mitul Gandhi, MD¹¹, Harsh R. Shah, DO¹², Wojciech Jurczak, MD, PhD¹³, Alessandro Re, MD^14*, Uwe Hahn^15*, H. Miles Prince, MD, MBBS¹⁶, Wenchuan Guo^17*, Griffith Davis^17*, Linda Ho^17*, Christopher Yasenchak, MD¹⁸ and Hun Ju Lee, MD¹⁹

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁴Rocky Mountain Cancer Centers, Aurora, CO
⁵Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁶Hospital Duran i Reynals, Institut Catala d’Oncologia, Hospitalet de Llobregat, Barcelona, Spain
⁷Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁸UCHealth Cancer Care and Hematology, Fort Collins, CO
⁹Miami Cancer Institute at Baptist Health, Inc., Miami, FL
¹⁰University of Tennessee Medical Center, Knoxville, TN
¹¹Virginia Cancer Specialists, US Oncology Research, Gainesville, VA
¹²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
¹⁴Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁵Royal Adelaide Hospital, Adelaide, Australia
¹⁶Epworth Freemasons, Melbourne, VIC, Australia
¹⁷Pfizer Inc., Bothell, WA
¹⁸Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
¹⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Jiayu Yang, MD¹, Diego Villa, MD^1,2, Alina S. Gerrie, MD, MPH^1,3, Petter Tonseth, MD^4*, Don C. Wilson^4*, Francois Benard, MD^4*, Graham W. Slack, MD^3,5*, Christopher P. Venner, MD^1,3, Andrea C. Lo, MD, MPH^3,6*, David W. Scott, MBChB, PhD^1,3, Laurie H. H. Sehn, MD^1,3 and Kerry J. Savage, MD, MSc^1,3

¹Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
²Centre for Lymphoid Cancer, BC Cancer – Vancouver Cancer Centre, Vancouver, BC, Canada
³Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁴Department of Radiology, University of British Columbia, Vancouver, BC, Canada
⁵Department of Pathology, University of British Columbia, Vancouver, BC, Canada
⁶Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada

Lisa Giulino Roth, MD¹, Mario Melgar Toledo^2*, Frank G. Keller^3*, Bradford Hoppe^4*, Christopher J. Forlenza, MD⁵, Sharon M. Castellino, MD, MSc³, Maitane Andión Catalan^6*, Julie Krystal^7*, Adam Lamble, MD⁸, Flavio Luisi^9*, Fabio Molina Morales^10*, Aarati V. Rao¹¹, Stacy Cooper¹², Oscar Gonzalez Llano^13*, Luis Juarez Villegas^14*, Christine Mauz-Koerholz, MD^15,16, Juan Shen^17*, Pallavi Pillai, MD¹⁷, Rushdia Yusuf¹⁷ and Kara M. Kelly, MD¹⁸

¹Weill Cornell Medicine, New York, NY
²Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala
³Children's Healthcare of Atlanta at Egleston, Atlanta, GA
⁴Mayo Clinic, Jacksonville, FL
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Hospital Infantil Universitario Niño Jesús, Madrid, Spain
⁷Cohen Children's Medical Center of New York, Queens, NY
⁸Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
⁹Instituto de Oncología Pediátrica—GRAACC—UNIFESP, São Paulo, Brazil
¹⁰Oncomédica S.A.S, Monteria, Colombia
¹¹Kaiser Permanente Roseville Medical Center, Roseville, CA
¹²Johns Hopkins University, Baltimore, MD
¹³Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
¹⁴Hospital Infantil de México Federico Gómez, Mexico City, Mexico
¹⁵Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Halle, Germany
¹⁶Justus-Liebig University of Giessen, Giessen, Germany
¹⁷Merck & Co., Inc., Rahway, NJ
¹⁸Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY